The Valley Desk

ArticleInflammatory intestinal diseasesPublished

Efficacy and Safety of Ustekinumab in Asian Patients with Moderately to Severely Active Ulcerative Colitis: A Subpopulation Analysis of UNIFI Long-Term Extension through 4 Years

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Inflammatory intestinal diseases
Published
Subject terms
Ulcerative colitis; Ustekinumab; Long-term Extension
PubMed ID
41583335
PubMed Central ID
PMC12826766
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal